Cheri Ackerman

Company: Concerto Biosciences

Job title: Co-Founder & CEO

Seminars:

Exploring ENS-002: A Microbiome-Based Therapy for Atopic Dermatitis 1:30 pm

Targeting Staphylococcus aureus by using a combination of three microbial strains to restore balance to the skin microbiome without immune suppression Evaluating ENS-002’s safety and tolerability in Phase 1 clinical trials, with a focus on its impact on S. aureus abundance and atopic dermatitis symptoms Anticipating Phase 2 trial results, which will provide further insights…Read more

day: Conference Day Two, Track Two, PM